✦ LIBER ✦

Pulmonary metastases from ameloblastoma of the mandible treated with cisplatin, adriamycin, and cyclophosphamide

✍ Scribed by K. Ramadas; C. C. Jose; J. Subhashini; Sushil M. Chandi; Faith R. Viswanathan

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 552 KB
Volume: 66
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19901001)66:7<1475::aid-cncr2820660707>3.0.co;2-d

No coin nor oath required. For personal study only.

✦ Synopsis

A case of delayed pulmonary metastases from an ameloblastoma of the mandible, which occurred 20 years after surgical resection of the primary tumor but with no recurrence at the primary site, is reported. Combination chemotherapy using cisplatin, adriamycin, and cyclophosphamide has produced a very good clinical and radiologically documented response in this case. Cancer 66

📜 SIMILAR VOLUMES

Treatment of advanced ovarian cancer wit

Treatment of advanced ovarian cancer with cisplatin, adriamycin, and cyclophosphamide: Effect of treatment and incidence of intracranial metastases

✍ G. Thomas Budd; Kenneth D. Webster; Ronald R. Reimer; Pierre Martimbeau; Robert 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

A retrospective analysis of 42 patients with stage 111, IV, or recurrcnt epithelial ovarian carcinoma treated with monthly cisplatin, Adriamycin, and cyclophosphamide (PAC) was made. Of 36 patients with measurable disease, 18 (50%) achieved a clinical complete response (CR) and 12 (33%) achieved a p

Decrease in clonogenic tumour cells in b

Decrease in clonogenic tumour cells in bone marrow aspirates from multiple myeloma patients due to the incorporation of cyclophosphamide into treatment with vincristine, adriamycin and methyl prednisolone

✍ Dr. J. B. G. Bell; B. C. Millar; A. Montes-Borinaga; J. K. Joffe; D. Cunningham; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 1 views

A study of 32 patients receiving cyclophosphamide (CY) and verapamil (VER) in addition to the drug combination vincristine, adriamycin and methyl prednisolone (VAMP) was made in which the clinical response and growth of clonogenic myeloma cells (MY-CFUJ from bone marrow aspirates were compared. At p